➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKinsey
McKesson
Baxter
Merck

Last Updated: January 27, 2021

DrugPatentWatch Database Preview

Litigation Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-07-06 15 Amended Complaint of United States Patent Nos. 8,921,348 (“’348 patent”), 9,829,495 (“’495 patent”), and 9,943,526 … States Patent (10) Patent No.: US 8,921,348 B2 … 300 mg, before the expiration of U.S. Patent Nos. 8,921,348 and 9,829,495....” 44. … 300 mg, before the expiration of U.S. Patent Nos. 8,921,348 and 9,829,495....” 52. … US 8,921,348 B2 1 External link to document
2020-06-23 152 Opinion regarding patent claims in Plaintiff’s U.S. Patent Nos. 8,921,348 (“the ʼ348 Patent”) and 9,829,495 (“the … The ’348 Patent and ’495 Patent, along with U.S. Patent No. 10,195,214 (“the ’214 Patent”), are collectively…regarding their request for patent claim construction pursuant to Local Patent Rule 4.5(a). This Court has…treatment by mifepristone.” (’348 Patent at Abstract.) 7 According to the patent, “administration of the same…produce excess cortisol. (’495 Patent at 1:23–24, 2:24– 29.) The ’495 Patent discloses a method to differentially External link to document
2018-10-23 31 Opinion the holder of patent numbers 8,921,348 (the “’348 patent”), 9,829,495 (the “’495 patent”) and 9,943,5269,943,526 (the “’526 patent”) (collectively, the “patents-in-suit”) and listed those patents in the Orange …process, applicants file “the patent number and the expiration date of any patent which claims the drug for…ANDAs must address patents that cover or might cover the relevant drugs. For each patent, companies can …Ex. A, B, C.) 1 The ‘348 patent was issued by the United States Patent and Trademark Office (“USPTO External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Medtronic
Baxter
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.